Dr. Schnittman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
950 Campbell Ave
West Haven, CT 06516Phone+1 203-932-5711- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1985 - 1989
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1982 - 1985
- New York University School of MedicineClass of 1982
Certifications & Licensure
- CT State Medical License 1998 - 2025
- MD State Medical License 1985 - 1999
- DC State Medical License 1989 - 1998
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 34 citationsZidovudine Treatment in Patients with Primary (Acute) Human Immunodeficiency Virus Type 1 Infection: A Randomized, Double-Blind, Placebo-Controlled TrialManette T. Niu, James Bethel, Mark Holodniy, Harold C. Standiford, Steven M. Schnittman> ;The Journal of Infectious Diseases. 1998 Jul 1
- 8 citationsHuman Immunodeficiency Virus Proviral DNA from Peripheral Blood and Lymph Nodes Demonstrates Concordant Resistance Mutations to Zidovudine (Codon 215) and Didanosine (...Douglas L. Mayers, James Bethel, Mark A. Wainberg, Owen S. Weislow, Steven M. Schnittman> ;The Journal of Infectious Diseases. 1998 Jun 1
- 105 citationsEvolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy.Giuseppe Pantaleo, Oren J. Cohen, Timothy W. Schacker, Mauro Vaccarezza, Cecilia Graziosi, Rizzardi Gp, James O. Kahn, Cecil H. Fox, Steven M. Schnittman, David H. Sch...> ;Nature Medicine. 1998 Mar 1
- Join now to see all
Press Mentions
- Biohaven Receives FDA May Proceed Letter to Begin Phase 2 Trial of Intranasal Vazegepant to Treat Lung Inflammation After COVID-19 InfectionApril 9th, 2020
Hospital Affiliations
- Griffin HospitalDerby, Connecticut
- Veterans Affairs Connecticut Healthcare SystemWest Haven, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: